Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia

Reglero, C., Dieck, C. L., Zask, A., Forouhar, F., Laurent, A. P., Lin, W.-H. W., Albero, R., Miller, H. I., Ma, C., Gastier-Foster, J. M., Loh, M. L., Tong, L., Stockwell, B. R., Palomero, T., & Ferrando, A. A. (2022). Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. Cancer Discovery, 12(11), 2646–2665. https://doi.org/10.1158/2159-8290.cd-22-0010
Authors:
Clara Reglero
Chelsea L Dieck
Arie Zask
Farhad Forouhar
Anouchka P Laurent
Wen-Hsuan W Lin
Robert Albero
Hannah I Miller
Cindy Ma
Julie M Gastier-Foster
Mignon L Loh
Liang Tong
Brent R Stockwell
Teresa Palomero
Adolfo A Ferrando
Affiliated Authors:
Clara Reglero
Chelsea L Dieck
Arie Zask
Farhad Forouhar
Anouchka P Laurent
Wen-Hsuan W Lin
Robert Albero
Hannah I Miller
Cindy Ma
Liang Tong
Brent R Stockwell
Teresa Palomero
Adolfo A Ferrando
Publication Type:
Article
Unique ID:
10.1158/2159-8290.cd-22-0010
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: